Avail up to 50% Thanksgiving Discount on all our reports. Stay safe

Global Anaplastic Astrocytoma Market Size, Status and Forecast 2018-2025

Date: Oct 15 2018
|
QYRESEARCH
|
Number of Pages: 99
|
Alternate Text Alternate Text Alternate Text Alternate Text
Category: Medical Care

Anaplastic astrocytoma is a rare malignant brain tumor.
Globally, North America contributed the highest revenues in anaplastic astrocytoma market due to deep reach of the treatments to the large number of population followed by Europe and Asia-Pacific regions as the second and third largest markets for Anaplastic astrocytoma.
In 2017, the global Anaplastic Astrocytoma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global Anaplastic Astrocytoma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anaplastic Astrocytoma development in United States, Europe and China.

The key players covered in this study
Genentech
Isarna Therapeutics
Axelar
Pfizer
Amgen
Novartis
Avid Bioservices
EirGen Pharma
Boehringer Ingelheim
Celldex Therapeutics

Market segment by Type, the product can be split into
Surgery
Radiation
Chemotherapy

Market segment by Application, split into
Pre-Registration Phase
Clinical Trail Phase

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Anaplastic Astrocytoma status, future forecast, growth opportunity, key market and key players.
To present the Anaplastic Astrocytoma development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Anaplastic Astrocytoma are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents
1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
           1.4.1 Global Anaplastic Astrocytoma Market Size Growth Rate by Type (2013-2025)
           1.4.2 Surgery
           1.4.3 Radiation
           1.4.4 Chemotherapy
    1.5 Market by Application
           1.5.1 Global Anaplastic Astrocytoma Market Share by Application (2013-2025)
           1.5.2 Pre-Registration Phase
           1.5.3 Clinical Trail Phase
    1.6 Study Objectives
    1.7 Years Considered
2 Global Growth Trends
    2.1 Anaplastic Astrocytoma Market Size
    2.2 Anaplastic Astrocytoma Growth Trends by Regions
           2.2.1 Anaplastic Astrocytoma Market Size by Regions (2013-2025)
           2.2.2 Anaplastic Astrocytoma Market Share by Regions (2013-2018)
    2.3 Industry Trends
           2.3.1 Market Top Trends
           2.3.2 Market Drivers
           2.3.3 Market Opportunities
3 Market Share by Key Players
    3.1 Anaplastic Astrocytoma Market Size by Manufacturers
           3.1.1 Global Anaplastic Astrocytoma Revenue by Manufacturers (2013-2018)
           3.1.2 Global Anaplastic Astrocytoma Revenue Market Share by Manufacturers (2013-2018)
           3.1.3 Global Anaplastic Astrocytoma Market Concentration Ratio (CR5 and HHI)
    3.2 Anaplastic Astrocytoma Key Players Head office and Area Served
    3.3 Key Players Anaplastic Astrocytoma Product/Solution/Service
    3.4 Date of Enter into Anaplastic Astrocytoma Market
    3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
    4.1 Global Anaplastic Astrocytoma Market Size by Type (2013-2018)
    4.2 Global Anaplastic Astrocytoma Market Size by Application (2013-2018)
5 United States
    5.1 United States Anaplastic Astrocytoma Market Size (2013-2018)
    5.2 Anaplastic Astrocytoma Key Players in United States
    5.3 United States Anaplastic Astrocytoma Market Size by Type
    5.4 United States Anaplastic Astrocytoma Market Size by Application
6 Europe
    6.1 Europe Anaplastic Astrocytoma Market Size (2013-2018)
    6.2 Anaplastic Astrocytoma Key Players in Europe
    6.3 Europe Anaplastic Astrocytoma Market Size by Type
    6.4 Europe Anaplastic Astrocytoma Market Size by Application
7 China
    7.1 China Anaplastic Astrocytoma Market Size (2013-2018)
    7.2 Anaplastic Astrocytoma Key Players in China
    7.3 China Anaplastic Astrocytoma Market Size by Type
    7.4 China Anaplastic Astrocytoma Market Size by Application
8 Japan
    8.1 Japan Anaplastic Astrocytoma Market Size (2013-2018)
    8.2 Anaplastic Astrocytoma Key Players in Japan
    8.3 Japan Anaplastic Astrocytoma Market Size by Type
    8.4 Japan Anaplastic Astrocytoma Market Size by Application
9 Southeast Asia
    9.1 Southeast Asia Anaplastic Astrocytoma Market Size (2013-2018)
    9.2 Anaplastic Astrocytoma Key Players in Southeast Asia
    9.3 Southeast Asia Anaplastic Astrocytoma Market Size by Type
    9.4 Southeast Asia Anaplastic Astrocytoma Market Size by Application
10 India
    10.1 India Anaplastic Astrocytoma Market Size (2013-2018)
    10.2 Anaplastic Astrocytoma Key Players in India
    10.3 India Anaplastic Astrocytoma Market Size by Type
    10.4 India Anaplastic Astrocytoma Market Size by Application
11 Central & South America
    11.1 Central & South America Anaplastic Astrocytoma Market Size (2013-2018)
    11.2 Anaplastic Astrocytoma Key Players in Central & South America
    11.3 Central & South America Anaplastic Astrocytoma Market Size by Type
    11.4 Central & South America Anaplastic Astrocytoma Market Size by Application
12 International Players Profiles
    12.1 Genentech
           12.1.1 Genentech Company Details
           12.1.2 Company Description and Business Overview
           12.1.3 Anaplastic Astrocytoma Introduction
           12.1.4 Genentech Revenue in Anaplastic Astrocytoma Business (2013-2018)
           12.1.5 Genentech Recent Development
    12.2 Isarna Therapeutics
           12.2.1 Isarna Therapeutics Company Details
           12.2.2 Company Description and Business Overview
           12.2.3 Anaplastic Astrocytoma Introduction
           12.2.4 Isarna Therapeutics Revenue in Anaplastic Astrocytoma Business (2013-2018)
           12.2.5 Isarna Therapeutics Recent Development
    12.3 Axelar
           12.3.1 Axelar Company Details
           12.3.2 Company Description and Business Overview
           12.3.3 Anaplastic Astrocytoma Introduction
           12.3.4 Axelar Revenue in Anaplastic Astrocytoma Business (2013-2018)
           12.3.5 Axelar Recent Development
    12.4 Pfizer
           12.4.1 Pfizer Company Details
           12.4.2 Company Description and Business Overview
           12.4.3 Anaplastic Astrocytoma Introduction
           12.4.4 Pfizer Revenue in Anaplastic Astrocytoma Business (2013-2018)
           12.4.5 Pfizer Recent Development
    12.5 Amgen
           12.5.1 Amgen Company Details
           12.5.2 Company Description and Business Overview
           12.5.3 Anaplastic Astrocytoma Introduction
           12.5.4 Amgen Revenue in Anaplastic Astrocytoma Business (2013-2018)
           12.5.5 Amgen Recent Development
    12.6 Novartis
           12.6.1 Novartis Company Details
           12.6.2 Company Description and Business Overview
           12.6.3 Anaplastic Astrocytoma Introduction
           12.6.4 Novartis Revenue in Anaplastic Astrocytoma Business (2013-2018)
           12.6.5 Novartis Recent Development
    12.7 Avid Bioservices
           12.7.1 Avid Bioservices Company Details
           12.7.2 Company Description and Business Overview
           12.7.3 Anaplastic Astrocytoma Introduction
           12.7.4 Avid Bioservices Revenue in Anaplastic Astrocytoma Business (2013-2018)
           12.7.5 Avid Bioservices Recent Development
    12.8 EirGen Pharma
           12.8.1 EirGen Pharma Company Details
           12.8.2 Company Description and Business Overview
           12.8.3 Anaplastic Astrocytoma Introduction
           12.8.4 EirGen Pharma Revenue in Anaplastic Astrocytoma Business (2013-2018)
           12.8.5 EirGen Pharma Recent Development
    12.9 Boehringer Ingelheim
           12.9.1 Boehringer Ingelheim Company Details
           12.9.2 Company Description and Business Overview
           12.9.3 Anaplastic Astrocytoma Introduction
           12.9.4 Boehringer Ingelheim Revenue in Anaplastic Astrocytoma Business (2013-2018)
           12.9.5 Boehringer Ingelheim Recent Development
    12.10 Celldex Therapeutics
           12.10.1 Celldex Therapeutics Company Details
           12.10.2 Company Description and Business Overview
           12.10.3 Anaplastic Astrocytoma Introduction
           12.10.4 Celldex Therapeutics Revenue in Anaplastic Astrocytoma Business (2013-2018)
           12.10.5 Celldex Therapeutics Recent Development
13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
    15.1 Research Methodology
           15.1.1 Methodology/Research Approach
                 15.1.1.1 Research Programs/Design
                 15.1.1.2 Market Size Estimation
                 12.1.1.3 Market Breakdown and Data Triangulation
           15.1.2 Data Source
                 15.1.2.1 Secondary Sources
                 15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details

List of Tables and Figures
Table Anaplastic Astrocytoma Key Market Segments
Table Key Players Anaplastic Astrocytoma Covered
Table Global Anaplastic Astrocytoma Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Anaplastic Astrocytoma Market Size Market Share by Type 2013-2025
Figure Surgery Figures
Table Key Players of Surgery
Figure Radiation Figures
Table Key Players of Radiation
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Table Global Anaplastic Astrocytoma Market Size Growth by Application 2013-2025 (Million US$)
Figure Pre-Registration Phase Case Studies
Figure Clinical Trail Phase Case Studies
Figure Anaplastic Astrocytoma Report Years Considered
Table Global Anaplastic Astrocytoma Market Size 2013-2025 (Million US$)
Figure Global Anaplastic Astrocytoma Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Anaplastic Astrocytoma Market Size by Regions 2013-2025 (Million US$)
Table Global Anaplastic Astrocytoma Market Size by Regions 2013-2018 (Million US$)
Table Global Anaplastic Astrocytoma Market Share by Regions 2013-2018
Figure Global Anaplastic Astrocytoma Market Share by Regions 2013-2018
Figure Global Anaplastic Astrocytoma Market Share by Regions 2018
Table Market Top Trends
Table Global Anaplastic Astrocytoma Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Anaplastic Astrocytoma Market Share by Manufacturers (2013-2018)
Figure Global Anaplastic Astrocytoma Market Share by Manufacturers in 2018
Table Global Anaplastic Astrocytoma Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Anaplastic Astrocytoma Product/Solution/Service
Table Date of Enter into Anaplastic Astrocytoma Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Anaplastic Astrocytoma Market Size by Type (2013-2018) (Million US$)
Table Global Anaplastic Astrocytoma Market Size Share by Type (2013-2018)
Figure Global Anaplastic Astrocytoma Market Size Market Share by Type (2013-2018)
Table Global Anaplastic Astrocytoma Market Size by Application (2013-2018) (Million US$)
Table Global Anaplastic Astrocytoma Market Size Share by Application (2013-2018)
Figure Global Anaplastic Astrocytoma Market Size Market Share by Application (2013-2018)
Figure Global Anaplastic Astrocytoma Revenue Market Share by Application in 2017
Figure United States Anaplastic Astrocytoma Market Size 2013-2018 (Million US$)
Table United States Key Players Anaplastic Astrocytoma Revenue (2017-2018) (Million US$)
Table United States Key Players Anaplastic Astrocytoma Market Share (2017-2018)
Table United States Anaplastic Astrocytoma Market Size by Type (2013-2018) (Million US$)
Table United States Anaplastic Astrocytoma Market Share by Type (2013-2018)
Table United States Anaplastic Astrocytoma Market Size by Application (2013-2018) (Million US$)
Table United States Anaplastic Astrocytoma Market Share by Application (2013-2018)
Figure Europe Anaplastic Astrocytoma Market Size 2013-2018 (Million US$)
Table Europe Key Players Anaplastic Astrocytoma Revenue (2017-2018) (Million US$)
Table Europe Key Players Anaplastic Astrocytoma Market Share (2017-2018)
Table Europe Anaplastic Astrocytoma Market Size by Type (2013-2018) (Million US$)
Table Europe Anaplastic Astrocytoma Market Share by Type (2013-2018)
Table Europe Anaplastic Astrocytoma Market Size by Application (2013-2018) (Million US$)
Table Europe Anaplastic Astrocytoma Market Share by Application (2013-2018)
Figure China Anaplastic Astrocytoma Market Size 2013-2018 (Million US$)
Table China Key Players Anaplastic Astrocytoma Revenue (2017-2018) (Million US$)
Table China Key Players Anaplastic Astrocytoma Market Share (2017-2018)
Table China Anaplastic Astrocytoma Market Size by Type (2013-2018) (Million US$)
Table China Anaplastic Astrocytoma Market Share by Type (2013-2018)
Table China Anaplastic Astrocytoma Market Size by Application (2013-2018) (Million US$)
Table China Anaplastic Astrocytoma Market Share by Application (2013-2018)
Figure Japan Anaplastic Astrocytoma Market Size 2013-2018 (Million US$)
Table Japan Key Players Anaplastic Astrocytoma Revenue (2017-2018) (Million US$)
Table Japan Key Players Anaplastic Astrocytoma Market Share (2017-2018)
Table Japan Anaplastic Astrocytoma Market Size by Type (2013-2018) (Million US$)
Table Japan Anaplastic Astrocytoma Market Share by Type (2013-2018)
Table Japan Anaplastic Astrocytoma Market Size by Application (2013-2018) (Million US$)
Table Japan Anaplastic Astrocytoma Market Share by Application (2013-2018)
Figure Southeast Asia Anaplastic Astrocytoma Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Anaplastic Astrocytoma Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Anaplastic Astrocytoma Market Share (2017-2018)
Table Southeast Asia Anaplastic Astrocytoma Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Anaplastic Astrocytoma Market Share by Type (2013-2018)
Table Southeast Asia Anaplastic Astrocytoma Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Anaplastic Astrocytoma Market Share by Application (2013-2018)
Figure India Anaplastic Astrocytoma Market Size 2013-2018 (Million US$)
Table India Key Players Anaplastic Astrocytoma Revenue (2017-2018) (Million US$)
Table India Key Players Anaplastic Astrocytoma Market Share (2017-2018)
Table India Anaplastic Astrocytoma Market Size by Type (2013-2018) (Million US$)
Table India Anaplastic Astrocytoma Market Share by Type (2013-2018)
Table India Anaplastic Astrocytoma Market Size by Application (2013-2018) (Million US$)
Table India Anaplastic Astrocytoma Market Share by Application (2013-2018)
Figure Central & South America Anaplastic Astrocytoma Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Anaplastic Astrocytoma Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Anaplastic Astrocytoma Market Share (2017-2018)
Table Central & South America Anaplastic Astrocytoma Market Size by Type (2013-2018) (Million US$)
Table Central & South America Anaplastic Astrocytoma Market Share by Type (2013-2018)
Table Central & South America Anaplastic Astrocytoma Market Size by Application (2013-2018) (Million US$)
Table Central & South America Anaplastic Astrocytoma Market Share by Application (2013-2018)
Table Genentech Company Details
Table Genentech Revenue in Anaplastic Astrocytoma Business (2013-2018) (Million US$)
Figure Genentech Revenue Growth Rate in Anaplastic Astrocytoma Business (2013-2018)
Table Genentech Recent Development
Table Isarna Therapeutics Company Details
Table Isarna Therapeutics Revenue in Anaplastic Astrocytoma Business (2013-2018)(Million US$)
Figure Isarna Therapeutics Revenue Growth Rate in Anaplastic Astrocytoma Business (2013-2018)
Table Isarna Therapeutics Recent Development
Table Axelar Company Details
Table Axelar Revenue in Anaplastic Astrocytoma Business (2013-2018)(Million US$)
Figure Axelar Revenue Growth Rate in Anaplastic Astrocytoma Business (2013-2018)
Table Axelar Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Anaplastic Astrocytoma Business (2013-2018)(Million US$)
Figure Pfizer Revenue Growth Rate in Anaplastic Astrocytoma Business (2013-2018)
Table Pfizer Recent Development
Table Amgen Company Details
Table Amgen Revenue in Anaplastic Astrocytoma Business (2013-2018)(Million US$)
Figure Amgen Revenue Growth Rate in Anaplastic Astrocytoma Business (2013-2018)
Table Amgen Recent Development
Table Novartis Company Details
Table Novartis Revenue in Anaplastic Astrocytoma Business (2013-2018)(Million US$)
Figure Novartis Revenue Growth Rate in Anaplastic Astrocytoma Business (2013-2018)
Table Novartis Recent Development
Table Avid Bioservices Company Details
Table Avid Bioservices Revenue in Anaplastic Astrocytoma Business (2013-2018)(Million US$)
Figure Avid Bioservices Revenue Growth Rate in Anaplastic Astrocytoma Business (2013-2018)
Table Avid Bioservices Recent Development
Table EirGen Pharma Company Details
Table EirGen Pharma Revenue in Anaplastic Astrocytoma Business (2013-2018)(Million US$)
Figure EirGen Pharma Revenue Growth Rate in Anaplastic Astrocytoma Business (2013-2018)
Table EirGen Pharma Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Anaplastic Astrocytoma Business (2013-2018)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Anaplastic Astrocytoma Business (2013-2018)
Table Boehringer Ingelheim Recent Development
Table Celldex Therapeutics Company Details
Table Celldex Therapeutics Revenue in Anaplastic Astrocytoma Business (2013-2018)(Million US$)
Figure Celldex Therapeutics Revenue Growth Rate in Anaplastic Astrocytoma Business (2013-2018)
Table Celldex Therapeutics Recent Development
Table Global Anaplastic Astrocytoma Market Size by Regions (Million US$) 2018-2025
Figure Global Anaplastic Astrocytoma Market Size Share by Regions (2018-2025)
Figure Global Anaplastic Astrocytoma Market Size Share by Regions in 2025
Figure United States Anaplastic Astrocytoma Market Size Forecast (2018-2025)(Million USD)
Figure Europe Anaplastic Astrocytoma Market Size Forecast (2018-2025)(Million USD)
Figure China Anaplastic Astrocytoma Market Size Forecast (2018-2025)(Million USD)
Figure Japan Anaplastic Astrocytoma Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Anaplastic Astrocytoma Market Size Forecast (2018-2025)(Million USD)
Figure India Anaplastic Astrocytoma Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Anaplastic Astrocytoma Market Size Forecast (2018-2025)(Million USD)
Table Global Anaplastic Astrocytoma Market Size by Product (2018-2025) (Million US$)
Figure Global Anaplastic Astrocytoma Market Size by Product (2018-2025)
Figure Global Anaplastic Astrocytoma Market Size by Product in 2025
Table Global Anaplastic Astrocytoma Market Size by Application (2018-2025) (Million US$)
Figure Global Anaplastic Astrocytoma Market Size by Application (2018-2025)
Figure Global Anaplastic Astrocytoma Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.